GlobalGov › Germany › Pharmaceuticals › Solicitation

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01

Health · Germany government procurement

Closed October 05, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedOctober 17, 2024
Procurement stageActive solicitation
ClosedOctober 05, 2026
StatusClosed — no longer accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Verbandmittel
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.11.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Bimatoprost (ATC-Code: S01EE03).
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Risperidon (ATC-Code N05AX08) eingeschränkt auf die Darreichung Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension.
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene, ATC V01AA05
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chinin, ATC M09AA02
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tetrabenazin (ATC-Code N07XX06).

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.